A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide.
Gamberi B, Berthou C, Hernandez M, Semenzato G, Tholouli E, Hájek R, Caers J, Dimopoulos M, Minnema MC, Andreasson B, Parreira J, Crotty G, Remes K, Kueenburg E, Rosettani B, Di Micco A, Peters S, Bacon P, Blau IW.
Gamberi B, et al. Among authors: bacon p.
Clin Lymphoma Myeloma Leuk. 2020 Oct;20(10):e629-e644. doi: 10.1016/j.clml.2020.05.006. Epub 2020 May 13.
Clin Lymphoma Myeloma Leuk. 2020.
PMID: 32605897
Free article.